Apellis Pharmaceuticals, Inc. (APLS)
40.41
+0.02
(+0.05%)
USD |
NASDAQ |
Apr 02, 16:00
40.55
+0.14
(+0.35%)
After-Hours: 04:57
Apellis Pharmaceuticals SG&A Expense (TTM) : 550.26M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biogen, Inc. | 2.434B |
| Eli Lilly & Co. | 11.09B |
| Agios Pharmaceuticals, Inc. | 180.28M |
| Scholar Rock Holding Corp. | 176.20M |
| BridgeBio Pharma, Inc. | 531.22M |